(Q57139599)

https://api.crossref.org/works/10.1177%2F107327481001700306

Gene expression predictors in breast cancer: current status, limitations and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481001700306

Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481001700306

Amplification patterns of three genomic regions predict distant recurrence in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481001700306

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481001700306

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481001700306

Genomic medicine. Gene expression tests foretell breast cancer's future

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481001700306

Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481001700306

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481001700306

The prognostic role of a gene signature from tumorigenic breast-cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481001700306

Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481001700306

The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481001700306

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481001700306

Tumor gene expression and prognosis in breast cancer patients with 10 or more positive lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481001700306

A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481001700306

Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481001700306

Converting a breast cancer microarray signature into a high-throughput diagnostic test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481001700306

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481001700306

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481001700306

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481001700306

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481001700306

Limits of predictive models using microarray data for breast cancer clinical treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481001700306

A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481001700306

The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481001700306

HOXB13-to-IL17BR expression ratio is related with tumor aggressiveness and response to tamoxifen of recurrent breast cancer: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481001700306

Concordance among gene-expression-based predictors for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481001700306

Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481001700306

An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481001700306